Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 14Unknown 6Recruiting 4Terminated 3Active not recruiting 2Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Pancreatic Neoplasms 1Pain, Postoperative 1Malignant Female Reproductive System Neoplasm 1Liver Neoplasms 1Kidney Neoplasms 1Duodenal Neoplasms 1Agnosia 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Hydromorphone × Clear all
NCT06525740 2026-03-04

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

Mayo Clinic

Phase 4 Recruiting
140 enrolled

Malignant Female Reproductive System Neoplasm

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting
128 enrolled
Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

NCT05842044 2025-09-05

No-PAIN

University of Miami

Phase 2 Recruiting
110 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡